These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 6165197)

  • 21. Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides.
    Copur MS; Deshpande A; Mleczko K; Norvell M; Hrnicek GJ; Woodward S; Frankforter S; Mandolfo N; Fu K; Chan WC
    Croat Med J; 2005 Jun; 46(3):458-62. PubMed ID: 15861527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
    Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
    Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfer factor therapy in mycosis fungoides: a double-blind study.
    Thestrup-Pedersen K; Grunnet E; Zachariae H
    Acta Derm Venereol; 1982; 62(1):47-53. PubMed ID: 6175137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small malignant melanoma in patients with mycosis fungoides.
    Amichai B; Grunwald MH; Goldstein J; Finkelstein E; Halevy S
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):155-7. PubMed ID: 9784043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.
    Talpur R; Venkatarajan S; Duvic M
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):591-7. PubMed ID: 25068889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mycosis fungoides. A form of pleuropulmonary origin with cutaneous sclerodermiform manifestations. Treatment by application of nitrogen mustard].
    Gueguen MH
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(6):617-8. PubMed ID: 5161189
    [No Abstract]   [Full Text] [Related]  

  • 27. Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience.
    Kim YH; Martinez G; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Feb; 139(2):165-73. PubMed ID: 12588222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of mycosis fungoides with topical nitrosourea compounds: Further studies.
    Zackheim HS; Epstein EH
    Arch Dermatol; 1975 Dec; 111(12):1564-70. PubMed ID: 1200661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical treatment of early cutaneous T-cell lymphoma.
    Ramsay DL; Meller JA; Zackheim HS
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):1031-56. PubMed ID: 8522483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remissions of mycosis fungoides induced by nitrogen mustard (HN2). Topical treatment and hydration of tumours and plaques with HN2. Topical desensitization to HN2. A clinical and histopathological controlled study.
    Volden G; Larsen TE
    Dermatologica; 1978; 156(3):129-41. PubMed ID: 342293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data.
    Liner K; Brown C; McGirt LY
    Drug Des Devel Ther; 2018; 12():241-254. PubMed ID: 29440874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides.
    Vonderheid EC
    Int J Dermatol; 1984 Apr; 23(3):180-6. PubMed ID: 6373639
    [No Abstract]   [Full Text] [Related]  

  • 33. Photochemotherapy and topical nitrogen mustard in the treatment of mycosis fungoides.
    du Vivier A; Vollum DI
    Br J Dermatol; 1980 Mar; 102(3):319-22. PubMed ID: 7370179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycosis fungoides in a lung transplant recipient with advanced ciclosporin nephropathy: management with mechlorethamine and subsequent renal transplantation.
    Laffitte E; Venetz JP; Aubert JD; Duchosal MA; Panizzon RG; Pascual M
    Dermatology; 2008; 217(1):87-8. PubMed ID: 18446031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical chemotherapy in mycosis fungoides.
    Grupper C; Durepaire R
    Bull Cancer; 1977; 64(2):323-34. PubMed ID: 912134
    [No Abstract]   [Full Text] [Related]  

  • 36. Ointment-based mechlorethamine treatment for mycosis fungoides.
    Price NM; Hoppe RT; Deneau DG
    Cancer; 1983 Dec; 52(12):2214-9. PubMed ID: 6640491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precautions for personnel applying topical nitrogen mustard to patients with mycosis fungoides.
    Thestrup-Pedersen K; Christiansen JV; Zachariae H
    Dermatologica; 1982 Aug; 165(2):108-13. PubMed ID: 7141061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitrogen mustard gel-induced inflammation triggers lymphomatoid papulosis in patients with mycosis fungoides.
    Trager MH; Chen C; Husain S; Geskin LJ
    J Dermatol; 2020 May; 47(5):546-550. PubMed ID: 32100361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary cancers, comorbidities and mortality associated with nitrogen mustard therapy in patients with mycosis fungoides: a 30-year population-based cohort study.
    Lindahl LM; Fenger-Grøn M; Iversen L
    Br J Dermatol; 2014 Mar; 170(3):699-704. PubMed ID: 24024659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.
    Estève E; Bagot M; Joly P; Souteyrand P; Beylot-Barry M; Vaillant L; Delaunay M; Avril MF; Laroche L; Grange F; Thomine E; Wechsler J
    Arch Dermatol; 1999 Nov; 135(11):1349-53. PubMed ID: 10566833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.